Denali Therapeutics's total assets for Q4 2025 were $1.14B, an increase of 8.45% from the previous quarter. DE:4DN total liabilities were $131.09M for the fiscal quarter, a 1.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.